Evidence that vildagliptin attenuates deterioration of glycaemic control during 2-year treatment of patients with type 2 diabetes and mild hyperglycaemia*-Reference-Cited by-同舟云学术

Evidence that vildagliptin attenuates deterioration of glycaemic control during 2-year treatment of patients with type 2 diabetes and mild hyperglycaemia*

Published:2008-11 Issue:11 Volume:10 Page:1114-1124
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:

Author:

Scherbaum W. A.,Schweizer A.,Mari A.,Nilsson P. M.,Lalanne G.,Wang Y.,Dunning B. E.,Foley J. E.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1463-1326.2008.00875.x/fullpdf

Reference23 articles.

1. Efficacy and tolerability of vildagliptin monotherapy in drug-naive patients with type 2 diabetes;Pi-Sunyer;Diabetes Res Clin Pract,2007

2. Vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed β-cell function in patients with type 2 diabetes;Mari;J Clin Endocrinol Metab,2005

3. Comparison between vildagliptin and metformin to sustain reductions in HbA1c over one year in drug-naïve patients with type 2 diabetes;Schweizer;Diabet Med,2007

4. Characterization of the influence of vildagliptin on model-assessed {beta}-cell function in patients with type 2 diabetes and mild hyperglycemia;Mari;J Clin Endocrinol Metab,2008

5. 5 Scherbaum WA , Schweizer A , Mari A et al. Efficacy and tolerability of vildagliptin in drug-naive patients with type 2 diabetes and mild hyperglycemia. Diabetes Obes Metab doi: 10.1111/j.1463-1326.2008.00850.

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beta‐cell function in type 2 diabetes (T2DM): Can it be preserved or enhanced?;Journal of Diabetes;2023-07-31

2. DPP-4 inhibitors for treating T2DM - hype or hope? an analysis based on the current literature;Frontiers in Molecular Biosciences;2023-05-23

3. Choice of Glucose-Lowering Drugs as Initial Monotherapy for Type 2 Diabetes Patients with Contraindications or Intolerance to Metformin: A Systematic Review and Meta-Analysis;Journal of Clinical Medicine;2022-11-30

4. Endogenous Glucose-Dependent Insulinotropic Polypeptide Contributes to Sitagliptin-Mediated Improvement in Beta Cell Function in Patients with Type 2 Diabetes;Diabetes;2022-07-07

5. Functional loss of pancreatic islets in type 2 diabetes: How can we halt it?;Metabolism;2020-09